Cargando…

Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection

BACKGROUND: The endoplasmic reticulum enzyme glucose-6-phosphatase catalyzes the common terminal reaction in the gluconeogenic/glycogenolytic pathways and plays a central role in glucose homeostasis. In most mammals, different G6PC subunits are encoded by three paralogous genes (G6PC, G6PC2, and G6P...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Daghri, Nasser M., Pontremoli, Chiara, Cagliani, Rachele, Forni, Diego, Alokail, Majed S., Al-Attas, Omar S., Sabico, Shaun, Riva, Stefania, Clerici, Mario, Sironi, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297017/
https://www.ncbi.nlm.nih.gov/pubmed/28173748
http://dx.doi.org/10.1186/s12862-017-0897-z
_version_ 1782505661662232576
author Al-Daghri, Nasser M.
Pontremoli, Chiara
Cagliani, Rachele
Forni, Diego
Alokail, Majed S.
Al-Attas, Omar S.
Sabico, Shaun
Riva, Stefania
Clerici, Mario
Sironi, Manuela
author_facet Al-Daghri, Nasser M.
Pontremoli, Chiara
Cagliani, Rachele
Forni, Diego
Alokail, Majed S.
Al-Attas, Omar S.
Sabico, Shaun
Riva, Stefania
Clerici, Mario
Sironi, Manuela
author_sort Al-Daghri, Nasser M.
collection PubMed
description BACKGROUND: The endoplasmic reticulum enzyme glucose-6-phosphatase catalyzes the common terminal reaction in the gluconeogenic/glycogenolytic pathways and plays a central role in glucose homeostasis. In most mammals, different G6PC subunits are encoded by three paralogous genes (G6PC, G6PC2, and G6PC3). Mutations in G6PC and G6PC3 are responsible for human mendelian diseases, whereas variants in G6PC2 are associated with fasting glucose (FG) levels. RESULTS: We analyzed the evolutionary history of G6Pase genes. Results indicated that the three paralogs originated during early vertebrate evolution and that negative selection was the major force shaping diversity at these genes in mammals. Nonetheless, site-wise estimation of evolutionary rates at corresponding sites revealed weak correlations, suggesting that mammalian G6Pases have evolved different structural features over time. We also detected pervasive positive selection at mammalian G6PC2. Most selected residues localize in the C-terminal protein region, where several human variants associated with FG levels also map. This region was re-sequenced in ~560 subjects from Saudi Arabia, 185 of whom suffering from type 2 diabetes (T2D). The frequency of rare missense and nonsense variants was not significantly different in T2D and controls. Association analysis with two common missense variants (V219L and S342C) revealed a weak but significant association for both SNPs when analyses were conditioned on rs560887, previously identified in a GWAS for FG. Two haplotypes were significantly associated with T2D with an opposite effect direction. CONCLUSIONS: We detected pervasive positive selection at mammalian G6PC2 genes and we suggest that distinct haplotypes at the G6PC2 locus modulate susceptibility to T2D. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12862-017-0897-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5297017
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52970172017-02-10 Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection Al-Daghri, Nasser M. Pontremoli, Chiara Cagliani, Rachele Forni, Diego Alokail, Majed S. Al-Attas, Omar S. Sabico, Shaun Riva, Stefania Clerici, Mario Sironi, Manuela BMC Evol Biol Research Article BACKGROUND: The endoplasmic reticulum enzyme glucose-6-phosphatase catalyzes the common terminal reaction in the gluconeogenic/glycogenolytic pathways and plays a central role in glucose homeostasis. In most mammals, different G6PC subunits are encoded by three paralogous genes (G6PC, G6PC2, and G6PC3). Mutations in G6PC and G6PC3 are responsible for human mendelian diseases, whereas variants in G6PC2 are associated with fasting glucose (FG) levels. RESULTS: We analyzed the evolutionary history of G6Pase genes. Results indicated that the three paralogs originated during early vertebrate evolution and that negative selection was the major force shaping diversity at these genes in mammals. Nonetheless, site-wise estimation of evolutionary rates at corresponding sites revealed weak correlations, suggesting that mammalian G6Pases have evolved different structural features over time. We also detected pervasive positive selection at mammalian G6PC2. Most selected residues localize in the C-terminal protein region, where several human variants associated with FG levels also map. This region was re-sequenced in ~560 subjects from Saudi Arabia, 185 of whom suffering from type 2 diabetes (T2D). The frequency of rare missense and nonsense variants was not significantly different in T2D and controls. Association analysis with two common missense variants (V219L and S342C) revealed a weak but significant association for both SNPs when analyses were conditioned on rs560887, previously identified in a GWAS for FG. Two haplotypes were significantly associated with T2D with an opposite effect direction. CONCLUSIONS: We detected pervasive positive selection at mammalian G6PC2 genes and we suggest that distinct haplotypes at the G6PC2 locus modulate susceptibility to T2D. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12862-017-0897-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-07 /pmc/articles/PMC5297017/ /pubmed/28173748 http://dx.doi.org/10.1186/s12862-017-0897-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Al-Daghri, Nasser M.
Pontremoli, Chiara
Cagliani, Rachele
Forni, Diego
Alokail, Majed S.
Al-Attas, Omar S.
Sabico, Shaun
Riva, Stefania
Clerici, Mario
Sironi, Manuela
Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection
title Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection
title_full Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection
title_fullStr Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection
title_full_unstemmed Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection
title_short Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection
title_sort susceptibility to type 2 diabetes may be modulated by haplotypes in g6pc2, a target of positive selection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297017/
https://www.ncbi.nlm.nih.gov/pubmed/28173748
http://dx.doi.org/10.1186/s12862-017-0897-z
work_keys_str_mv AT aldaghrinasserm susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection
AT pontremolichiara susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection
AT caglianirachele susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection
AT fornidiego susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection
AT alokailmajeds susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection
AT alattasomars susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection
AT sabicoshaun susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection
AT rivastefania susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection
AT clericimario susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection
AT sironimanuela susceptibilitytotype2diabetesmaybemodulatedbyhaplotypesing6pc2atargetofpositiveselection